Standing Order
Lantheus Holdings, Inc.

Dashboard

Lantheus Holdings, Inc.

LNTHNASDAQ

For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.

Universal block

Live market data + trailing fundamentals.

Market cap$6.7B
Price$102.1052w $50.11 – $110.94
Conviction4/ 5
Revenue (TTM)$1.6B
Revenue growth YoY+2.4%
P/E (trailing)24.7
Gross margin61.3%
Operating margin18.6%
Net margin17.3%
52w price change+32.4%
Next earnings—

Recent events

Material filings, federal awards, and regulatory activity. Impact is scored against market cap.

  • Nov 19
    Ownership changeSEC

    Form 4 filing reporting change in beneficial ownership of securities.

  • Nov 10
    OtherSEC

    8-K filing (item 8.01) on November 10, 2026.

  • Nov 5
    Financial resultsSEC

    Lantheus Holdings filed 8-K with items 2.02 and 9.01 disclosing results of operations.

  • Oct 22
    OtherSEC

    Lantheus Holdings filed Form 8-K item 8.01 other events on 2026-10-22.

  • Oct 14
    OtherSEC

    Lantheus Holdings filed 8-K item 5.07 reporting results of matters submitted to a shareholder vote.

  • Oct 2
    OtherSEC

    Lantheus Holdings filed Form 8-K item 8.01 on 2026-10-02.

  • Sep 21
    OtherSEC

    8-K filed under item 8.01 (other events).

  • Sep 8
    Ownership changeSEC

    Form 4 filing reporting change in beneficial ownership of securities by an insider.

  • Sep 8
    M&ASEC

    Filed DEFM14A definitive proxy statement for merger or acquisition.

  • Sep 4
    Ownership changeSEC

    Form 4 filing reporting change in beneficial ownership of securities.

  • Sep 3
    Ownership changeSEC

    Form 4 filing: statement of changes in beneficial ownership of securities.

  • Sep 2
    Ownership changeSEC

    Form 4 filing: statement of changes in beneficial ownership of securities.

  • Sep 2
    Ownership changeSEC

    Form 4 filing reporting change in beneficial ownership of securities.

  • Aug 26
    M&ASEC

    PREM14A preliminary proxy statement filed for merger or acquisition.

  • Aug 19
    Ownership changeSEC

    Form 4 filing: statement of changes in beneficial ownership of securities.

  • Aug 19
    Ownership changeSEC

    Form 4 filing: statement of changes in beneficial ownership of securities.

  • Aug 6
    Financial resultsSEC

    Lantheus Holdings files 8-K (items 2.02, 9.01) disclosing results of operations and financial condition.

  • Aug 4
    LeadershipSEC

    8-K reports entry into material definitive agreement (item 1.01) and officer/director changes (item 5.02).

  • Aug 3
    OtherSEC

    Lantheus Holdings files 8-K covering items 7.01 (Reg FD), 8.01 (other events), and 9.01 (exhibits).

  • Jul 22
    RegulatoryFDA

    FDA supplemental submission (SUPPL-41) action for NEURACEQ under NDA204677.

Not financial advice — research and opinion only. Disclosures